UNLABELLED: Depression is associated with systemic inflammation, and the systemic inflammation caused by endotoxin administration elicits mild depressive symptoms such as fatigue and reduced interest. The neural correlates of depressive symptoms that result from systemic inflammation are poorly defined. The aim of this study was to use (18)F-FDG PET to identify brain regions involved in the response to endotoxin administration in humans. METHODS:Nine healthy subjects received double-blind endotoxin (0.8 ng/kg) and placebo on different days. (18)F-FDG PET was used to measure differences in the cerebral metabolic rate of glucose in the following regions of interest: insula, cingulate, and amygdala. Serum levels of tumor necrosis factor-α and interleukin-6 were used to gauge the systemic inflammatory response, and depressive symptoms were measured with the Montgomery-Åsberg Depression Rating Scale and other scales. RESULTS:Endotoxin administration was associated with an increase in Montgomery-Åsberg Depression Rating Scale, increased fatigue, reduced social interest, increased levels of inflammatory cytokines, higher normalized glucose metabolism (NGM) in the insula, and, at a trend level, lower NGM in the cingulate. Secondary analyses of insula and cingulate subregions indicated that these changes were driven by the right anterior insula and the right anterior cingulate. There was a negative correlation between peak cytokine levels and change in social interest and between peak cytokine levels and change in insula NGM. There was a positive correlation between the change in NGM in the insula and change in social interest. CONCLUSION: Systemic inflammation in humans causes an increase in depressive symptoms and concurrent changes in glucose metabolism in the insula and cingulate-brain regions that are involved in interoception, positive emotionality, and motivation.
RCT Entities:
UNLABELLED: Depression is associated with systemic inflammation, and the systemic inflammation caused by endotoxin administration elicits mild depressive symptoms such as fatigue and reduced interest. The neural correlates of depressive symptoms that result from systemic inflammation are poorly defined. The aim of this study was to use (18)F-FDG PET to identify brain regions involved in the response to endotoxin administration in humans. METHODS: Nine healthy subjects received double-blind endotoxin (0.8 ng/kg) and placebo on different days. (18)F-FDG PET was used to measure differences in the cerebral metabolic rate of glucose in the following regions of interest: insula, cingulate, and amygdala. Serum levels of tumor necrosis factor-α and interleukin-6 were used to gauge the systemic inflammatory response, and depressive symptoms were measured with the Montgomery-Åsberg Depression Rating Scale and other scales. RESULTS: Endotoxin administration was associated with an increase in Montgomery-Åsberg Depression Rating Scale, increased fatigue, reduced social interest, increased levels of inflammatory cytokines, higher normalized glucose metabolism (NGM) in the insula, and, at a trend level, lower NGM in the cingulate. Secondary analyses of insula and cingulate subregions indicated that these changes were driven by the right anterior insula and the right anterior cingulate. There was a negative correlation between peak cytokine levels and change in social interest and between peak cytokine levels and change in insula NGM. There was a positive correlation between the change in NGM in the insula and change in social interest. CONCLUSION:Systemic inflammation in humans causes an increase in depressive symptoms and concurrent changes in glucose metabolism in the insula and cingulate-brain regions that are involved in interoception, positive emotionality, and motivation.
Authors: Nikos Makris; Jill M Goldstein; David Kennedy; Steven M Hodge; Verne S Caviness; Stephen V Faraone; Ming T Tsuang; Larry J Seidman Journal: Schizophr Res Date: 2006-01-31 Impact factor: 4.939
Authors: Lucile Capuron; Giuseppe Pagnoni; Marina F Demetrashvili; David H Lawson; Fiona B Fornwalt; Bobbi Woolwine; Gregory S Berns; Charles B Nemeroff; Andrew H Miller Journal: Neuropsychopharmacology Date: 2007-02-28 Impact factor: 7.853
Authors: Romola S Bucks; Yori Gidron; Petra Harris; Jessica Teeling; Keith A Wesnes; V Hugh Perry Journal: Brain Behav Immun Date: 2007-10-29 Impact factor: 7.217
Authors: Naomi I Eisenberger; Tristen K Inagaki; Lian T Rameson; Nehjla M Mashal; Michael R Irwin Journal: Neuroimage Date: 2009-04-17 Impact factor: 6.556
Authors: Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Hugo D Critchley Journal: Biol Psychiatry Date: 2009-05-07 Impact factor: 13.382
Authors: Neil A Harrison; Lena Brydon; Cicely Walker; Marcus A Gray; Andrew Steptoe; Raymond J Dolan; Hugo D Critchley Journal: Biol Psychiatry Date: 2009-05-01 Impact factor: 13.382
Authors: Jonas Hannestad; Jean-Dominique Gallezot; Thomas Schafbauer; Keunpoong Lim; Tracy Kloczynski; Evan D Morris; Richard E Carson; Yu-Shin Ding; Kelly P Cosgrove Journal: Neuroimage Date: 2012-07-06 Impact factor: 6.556
Authors: Christine M Sandiego; Jean-Dominique Gallezot; Brian Pittman; Nabeel Nabulsi; Keunpoong Lim; Shu-Fei Lin; David Matuskey; Jae-Yun Lee; Kevin C O'Connor; Yiyun Huang; Richard E Carson; Jonas Hannestad; Kelly P Cosgrove Journal: Proc Natl Acad Sci U S A Date: 2015-09-18 Impact factor: 11.205
Authors: Verica Milivojevic; Emily Ansell; Christine Simpson; Kristen M Siedlarz; Rajita Sinha; Helen C Fox Journal: Alcohol Clin Exp Res Date: 2017-02-01 Impact factor: 3.455
Authors: Elaine Setiawan; Alan A Wilson; Romina Mizrahi; Pablo M Rusjan; Laura Miler; Grazyna Rajkowska; Ivonne Suridjan; James L Kennedy; P Vivien Rekkas; Sylvain Houle; Jeffrey H Meyer Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: Kristen N Warren; Lori L Beason-Held; Olga Carlson; Josephine M Egan; Yang An; Jimit Doshi; Christos Davatzikos; Luigi Ferrucci; Susan M Resnick Journal: J Gerontol A Biol Sci Med Sci Date: 2018-05-09 Impact factor: 6.053
Authors: K L Pomykala; P A Ganz; J E Bower; L Kwan; S A Castellon; S Mallam; I Cheng; R Ahn; E C Breen; M R Irwin; D H S Silverman Journal: Brain Imaging Behav Date: 2013-12 Impact factor: 3.978
Authors: Jonas Hannestad; Nicole DellaGioia; Jean-Dominique Gallezot; Keunpoong Lim; Nabeel Nabulsi; Irina Esterlis; Brian Pittman; Jae-Yun Lee; Kevin C O'Connor; Daniel Pelletier; Richard E Carson Journal: Brain Behav Immun Date: 2013-07-09 Impact factor: 7.217